In a surprising medical revelation this year, researchers have confirmed what many women over 40 suspected for years: ...
Bedrock Bioscience announced the Gazelle™ Chair, an advanced, non-invasive treatment designed to help patients regain control ...
Aura Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights
Accelerated Phase 3 CoMpass Enrollment Supports Mid-2026 Enrollment Completion and 2H 2027 Topline Data GuidancePhase 1b/2 NMIBC Trial on Track: ...
Diagnostic test based on urinary tumor markers hold promise for earlier or prompt detection of bladder cancer in patients ...
ImmunityBio has achieved a significant regulatory milestone, with the U.S. Food and Drug Administration (FDA) formally acknowledging receipt of its supplemental ...
Positive 12-month Phase 2 data for NDV-01 in non-muscle invasive bladder cancer (NMIBC) demonstrated a 95% complete response ...
A growing body of research seeks to validate ctDNA as a means of guiding MIBC treatment, particularly immunotherapy.
MHN has signed support of 2 policies: a Bladder Cancer Research Program within DoD & recognition of post-baccalaureate nursing degrees as professional degrees. Expanding the workforce of nurses & ...
Colorblindness may be doing more than making traffic lights confusing — it could also be hiding a life-threatening warning sign. Researchers analyzing millions of medical records found that people ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results